Showing results (201-210 of 610) with videos related to
Sort By:
Pageof 61
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 28, 2009
The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma?Athanasios Tsianakas, Meinhard Schiller, Thomas A Luger, et al.Molecular and Cellular Endocrinology|September 22, 1995
Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblastsA Palmetshofer, D Zechner, T A Luger, et al.Journal of the American Academy of Dermatology|May 1, 1996
Mycosis fungoides presenting as an acquired ichthyosisB Kütting, D Metze, T A Luger, et al.Experimental Dermatology|February 1, 1997
Pentoxifylline reduces the formation of sunburn cellsA Schwarz, K Mahnke, T A Luger, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activityT Schwarz, A Urbanska, F Gschnait, et al.Journal of Medical Virology|January 19, 1999
Modelling long-term persistence of hepatitis B antibodies after vaccinationA Vellinga, P Van Damme, L Bruckers, et al.The Journal of Reproductive Medicine|March 1, 1995
Mass antimicrobial treatment in pregnancy. A randomized, placebo-controlled trial in a population with high rates of sexually transmitted diseasesM Temmerman, E Njagi, N Nagelkerke, et al.Journal of Medical Virology|December 1, 1994
Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistenceP Van Damme, S Thoelen, M Cramm, et al.Antimicrobial Agents and Chemotherapy|April 1, 1979
Antibiotic susceptibility of Neisseria gonorrhoeae strains from Europe and AfricaP Piot, E van Dyck, J Colaert, et al.Journal of Medical Virology|December 1, 1994
Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicityP Van Damme, C Matheï, S Thoelen, et al.Pageof 61